REG - Craneware plc - AGM Statement and Board Changes

CranewareAnnouncement

Today 07:00

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20251121:nRSU4496Ia&default-theme=true

RNS Number : 4496I  Craneware plc  21 November 2025

Craneware plc

("Craneware" or the "Company")

 

AGM Statement and Board Changes

 

21 November 2025 - Craneware (AIM: CRW.L), a leader in healthcare financial
performance solutions, provides an update on trading ahead of its Annual
General Meeting, taking place at 10am today.

 

The Board is pleased to confirm that following the growth reported in FY25,
the start of FY26 has seen the positive momentum continue. Alongside the
Group's direct sales efforts, the alliance with Microsoft is progressing well,
adding significant sales pipeline growth as well as continuing to help drive
innovation. US healthcare providers remain focused on optimising their
operational and financial performance, driving demand for the Group's
solutions.

 

The Group continues to invest in R&D to strengthen its product set,
leveraging its proprietary data assets to expand its offerings and launch new
AI enabled applications. A recent area of focus has been the accelerated
development of a product to support customers through the 340B drug rebate
pilot program, whereby participating hospitals have to purchase an initial 9
named drugs at wholesale acquisition cost and later apply for manufacturer
rebates. This program, announced on 30 October 2025 by the Health Resources
and Services Administration ("HRSA"), is due to commence on 1 January 2026,
creating further operational and administrative complexities for healthcare
providers. As a result of prior investments in the Trisus platform, the depth
of Craneware's data and its unique position of independence in the 340B vendor
market, the Company has successfully brought this fully integrated solution to
market in an accelerated timeframe, supporting its customers by reducing their
financial risk, maintaining compliance and protecting resources for patient
care. Having demonstrated the product through live meetings and a series of
webinars, the solution is now being rolled out ahead of the deadline and is a
testament to Craneware's leading position in the 340B market.

 

Board Changes

 

As previously announced, following many years of service on the Board of
Directors, David Kemp, Senior Non-Executive Director, has decided not to stand
for re-election at the Company's AGM later today and as a result, will retire
from the Board following the close of the meeting. The Board thanks him for
his significant contributions during his tenure. His insight and constructive
challenge have been invaluable, helping drive Craneware's success.

 

Following the completion of the AGM, Alistair Erskine will assume the role of
Senior Independent Director, Susan Nelson will assume the role of Chair of the
Audit Committee and Jill Goldsmith will take over the role of Company
Secretary to the Board.

 

Outlook

 

The strength of the Company's Annuity SaaS business model and balance sheet,
its high levels of recurring revenue and strong cash generation provide
Craneware with solid foundations as it executes on its growth strategy and the
creation of long-term value for all stakeholders.

 

The Board remains confident in the delivery of continued growth over the near
term, and the Group continues to trade in line with market expectations for
the year.

 

For further information, please contact:

 

 Craneware plc                                     +44 (0)131 550 3100
 Keith Neilson, CEO
 Craig Preston, CFO

 Alma Strategic Communications                     +44 (0)20 3405 0205
 Caroline Forde, Kinvara Verdon, Sarah Peters      craneware@almastrategic.com

 Peel Hunt (NOMAD and Joint Broker)                +44 (0)20 7418 8900
 Neil Patel, Benjamin Cryer, Kate Bannatyne

 Investec Bank PLC (Joint Broker)                  +44 (0)20 7597 5970
 Patrick Robb, Virginia Bull, Arnav Kapoor

 Berenberg (Joint Broker)                          +44 (0)20 3207 7800
 Mark Whitmore, Richard Andrews, Patrick Dologhan

 

About Craneware

 

For over 25 years, The Craneware Group (AIM:CRW.L) has been a leader in
healthcare financial and operational transformation, delivering cutting-edge
technologies that drive measurable impact. Our Trisus® cloud ecosystem
unifies data, revenue intelligence, margin intelligence, and advanced
analytics, enabling healthcare organizations to optimize performance, improve
financial sustainability, and drive strategic growth. As a trusted Microsoft
partner, we provide future-ready solutions-including the Best in KLAS Trisus
Chargemaster - that simplify the complexities of healthcare finance and
operations. What sets us apart is our unique combination of deep healthcare
expertise and engineering excellence, positioning us as a strategic partner
rather than just a technology provider. The Craneware Group empowers
healthcare organizations to achieve sustainable financial success while
delivering better outcomes for the communities they serve - today and in the
future. Together, we are transforming the business of healthcare.

 

Learn more at www.thecranewaregroup.com

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  AGMFFFSILRLIFIE



            Copyright 2019 Regulatory News Service, all rights reserved